Prostate Cancer - Results from #24320

The unfolding treatment landscape for men with castration-resistant prostate cancer - Abstract November 28, 2012

Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer November 28, 2012

AACR and Millennium partner to offer two new grant opportunities for lymphoma research and prostate cancer research November 28, 2012

Radiotherapy with androgen deprivation in high-risk prostate cancer: What outcomes on a Caribbean population? - Abstract November 28, 2012

Small cell cancer of the prostate - Abstract November 28, 2012

Purposeful interaction: Ways Latino men communicate about prostate cancer - Abstract November 28, 2012

External beam radiotherapy in the treatment of prostate cancer - Abstract November 28, 2012

Systemic bias in the medical literature on androgen deprivation therapy and its implication to clinical practice - Abstract November 27, 2012

Dietary folate and folate vitamers and the risk of prostate cancer in The Netherlands Cohort Study - Abstract November 27, 2012

PSA implications and medical management of prostate cancer for the primary care physician - Abstract November 27, 2012

Androgen deprivation therapy for prostate cancer and osteoporotic risk - Abstract November 27, 2012

Urinary continence following laparoscopic radical prostatectomy: Qualitative analysis - Abstract November 27, 2012

NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy - Abstract November 27, 2012

Expression patterns of epithelial-mesenchymal transition markers in localized prostate cancer: Significance in clinicopathological outcomes following radical prostatectomy - Abstract November 27, 2012

Progress in emerging therapies for advanced prostate cancer - Abstract November 27, 2012

Socioeconomic and clinical factors influence the interval between positive prostate biopsy and radical prostatectomy - Abstract November 27, 2012

Prostate cancers of different zonal origin: Clinicopathological characteristics and biochemical outcome after radical prostatectomy - Abstract November 27, 2012

Role of immediate confirmatory prostate biopsy to ensure accurate eligibility for active surveillance - Abstract November 27, 2012

Free prostate-specific antigen is a better tool than total prostate-specific antigen at predicting prostate volume in patients with lower urinary tract symptoms - Abstract November 27, 2012

Interactive Case-Lecture Series - Advances in Treating Metastatic Castration Resistant Prostate Cancer November 27, 2012

Page 1217 of 1436